Print

Ligand Pharmaceuticals Inc. (LGND) to Report Fourth Quarter Results on February 13th  
1/23/2013 7:05:47 AM

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report fourth quarter 2012 financial results on Wednesday, February 13, 2013. Ligand’s President and CEO, John L. Higgins, Executive Vice President and COO, Matt Foehr and Vice President of Finance and CFO, John Sharp will host the conference call.
//-->